BNGO - Buy This Magnificent Growth Stock Before It's Too Late
2023-03-16 09:57:00 ET
While it's true that the risks of an investment in an earlier-stage business are higher, there's sometimes a sweet spot where the largest portion of the risk burden is decreasing, but the market hasn't bid up the stock's price accordingly yet.
Bionano Genomics (NASDAQ: BNGO) appears to be in just that place -- at the start of its growth journey -- and it could be a great way to give your portfolio some additional upside potential. Here's why you should consider buying the stock now.
Bionano's claim to fame is its laboratory analyzer device for optical genome mapping, which it calls the Saphyr. The point of the machine is that it can identify and characterize structural variations in genomes; those structural variations are highly relevant for human health, and aberrant variants are responsible for causing conditions like Down's syndrome as well as some cancers.
For further details see:
Buy This Magnificent Growth Stock Before It's Too Late